| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.4M | -61.6% | -59.6% |
| R&D Expense | $8.6M | -19.4% | -68.0% |
| SG&A Expense | $4.2M | -29.0% | -19.7% |
| Operating Income | -$7.9M | -223.9% | +57.4% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$7.4M | -334.2% | +56.9% |
| EPS (Basic) | -$0.13 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.6M | +55.9% | -36.3% |
| Current Assets | $52.3M | -11.9% | -60.2% |
| Total Assets | $54.2M | -12.8% | -59.9% |
| Current Liabilities | $13.6M | -8.7% | -72.2% |
| Total Liabilities | $27.7M | -5.5% | -60.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | — |
| +59.4% |
| EPS (Diluted) | -$0.13 | -333.3% | +59.4% |
| $26.5M |
| -19.3% |
| -59.6% |